See also this year's filing and all EDGAR filings for this company.
PDF Report 0001311241_2018_Intermolecular_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001311241')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001311241, Intermolecular INC
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesCurrent | 5,269,000 |
| 1 | LiabilitiesNonCurrent | 28,000 |
| 2 | remainder_Liabilities | 2,939,000 |
| 3 | AssetsCurrent | 30,738,000 |
| 4 | AssetsNonCurrent | 600,000 |
| 5 | IntangibleAssets | 2,620,000 |
| 6 | PropertyPlantAndEquipmentNet | 5,913,000 |
| 7 | remainder_Assets | 4,438,000 |
| 8 | ResearchAndDevelopmentExpense | 21,535,000 |
| 9 | SellingGeneralAndAdministrativeExpense | 13,217,000 |
| 10 | AmortizationOfIntangibleAssets | 0 |
| 11 | remainder_Expenses | 13,457,000 |
| 12 | remainder_Revenues | 37,203,000 |
| 13 | remainder_NetIncome | 603,000 |
| 14 | remainder_ComprehensiveNetIncome | -3,000 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 8,236,000 |
| 1 | Assets | 44,309,000 |
| 2 | Expenses | 48,209,000 |
| 3 | Revenues | 37,203,000 |
| 4 | StockholdersEquity | 36,073,000 |
| 5 | NetIncome | -10,403,000 |
| 6 | ComprehensiveNetIncome | -10,406,000 |
| 7 | BaseVar | 190,996,970 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.70 |
| 9 | EconomicCapitalRatio | 1.86 |
Edgar->Model Mapping
Feature Distribution
Change over Time
